Pimavanserin for negative symptoms of schizophrenia: Results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and Europe - Bugarski-Kirola, D; Arango, C; Fava, M (Lancet Psychiatry, 2022)
et al.